WCN26-1998 Telitacicept treatment for IgA nephropathy after liver transplantation:a case report

Read full text Summarise with VIRAT
Authors: Jie Sheng, Meixi Wang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In recent years, liver transplantation has emerged as a crucial therapeutic option for patients with end-stage liver disease. With the increasing number of individuals undergoing transplantation and the extended survival time of these patients, kidney damage following liver transplantation has gradually garnered attention. According to reports, kidney lesions after liver transplantation include various pathological types such as calcineurin inhibitors (CNIs) nephrotoxicity, IgAN, and focal segmental glomerulosclerosis (FSGS), et al.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Complement system in diseases

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104420–104420
Publication date
25 March 2026
Language
EN